Helicobacter pylori and primary gastric lymphoma: A histopathologic and immunohistochemical analysis of 237 patients

S Nakamura, T Yao, K Aoyagi, M Iida… - … Journal of the …, 1997 - Wiley Online Library
BACKGROUND Few previous articles have analyzed the relation between infection with
Helicobacter pylori (H. pylori) and primary gastric lymphoma in a large number of patients. …

AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised …

…, T Nishikawa, H Takedatsu, K Aoyagi… - The Lancet …, 2022 - thelancet.com
Background AJM300 is an oral, small-molecule α4-integrin antagonist. We assessed the
efficacy and safety of AJM300 in patients with moderately active ulcerative colitis. Methods This …

Impact of Helicobacter pylori infection on gastric cancer incidence in a general Japanese population: the Hisayama study

H Yamagata, Y Kiyohara, K Aoyagi, I Kato… - Archives of Internal …, 2000 - jamanetwork.com
Background Several nested case-control studies have reported the potentially causal relationship
betweenHelicobacter pyloriinfection and the development of gastric cancer. However, …

[HTML][HTML] A Hereditary Enteropathy Caused by Mutations in the SLCO2A1 Gene, Encoding a Prostaglandin Transporter

…, N Hosoe, H Ogata, T Watanabe, K Aoyagi… - PLoS …, 2015 - journals.plos.org
Previously, we proposed a rare autosomal recessive inherited enteropathy characterized by
persistent blood and protein loss from the small intestine as chronic nonspecific multiple …

Synchronous and metachronous primary gastric lymphoma and adenocarcinoma: a clinicopathologic study of 12 patients

S Nakamura, K Aoyagi, S Iwanaga, T Yao… - Cancer, 1997 - Wiley Online Library
BACKGROUND The occurrence of both malignant gastric lymphoma and adenocarcinoma
in the same patient is very rare. METHODS The resected specimens from 12 patients who …

Short‐term efficacy of enteral nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas

…, T Yao, Y Takagi, F Hirai, K Aoyagi… - Journal of parenteral …, 2002 - Wiley Online Library
BACKGROUND: The optimal dietary fat content to induce clinical remission in active
Crohn's disease has been the subject of controversy. We therefore performed a prospective, …

[HTML][HTML] Effectiveness of concomitant enteral nutrition therapy and infliximab for maintenance treatment of Crohn's disease in adults

…, S Ashizuka, H Inatsu, H Ohi, K Aoyagi… - Digestive Diseases and …, 2013 - Springer
Background One of the problems associated with infliximab (IFX) treatment for Crohn’s disease
(CD) is loss of response during maintenance therapy. Aims The aim of this multicenter, …

B-cell monoclonality precedes the development of gastric MALT lymphoma in Helicobacter pylori-associated chronic gastritis.

S Nakamura, K Aoyagi, M Furuse… - The American journal …, 1998 - ncbi.nlm.nih.gov
Little is known about the temporal changes in Helicobacter pylori density and B-cell clonality
during the evolution from chronic gastritis to gastric mucosa-associated lymphoid tissue (…

Juvenile polyposis of the stomach: clinicopathological features and its malignant potential.

K Hizawa, M Iida, T Yao, K Aoyagi… - Journal of clinical …, 1997 - jcp.bmj.com
AIMS: To clarify a clinical entity of juvenile polyposis of the stomach compared with
generalised juvenile gastrointestinal polyposis. METHODS: The clinicopathological features of …

[HTML][HTML] Activation of myofibroblast TRPA1 by steroids and pirfenidone ameliorates fibrosis in experimental Crohn's disease

…, Y Hu, K Koga, M Onitsuka, M Doi, K Aoyagi… - Cellular and molecular …, 2018 - Elsevier
Background & Aims The transient receptor potential ankyrin 1 (TRPA1) channel is highly
expressed in the intestinal lamina propria, but its contribution to gut physiology/pathophysiology …